Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-27

Clinical Trial Update: Glucose Tolerance, Meal Timing and MTNR1B [NA]

View source ↗

Summary

A completed clinical trial examining glucose tolerance in relation to meal timing and MTNR1B in individuals with a non-diabetic endocrine pancreas disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universidad de Murcia | Conditions: Non-Diabetic Disorder of Endocrine Pancreas | NA | Status: COMPLETED